QT
ITOS

Quantbot Technologies’s iTeos Therapeutics ITOS Stock Holding History

Quantbot Technologies’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,700
Closed -$51.5K – 1782
2023
Q3 		$51.5K Buy
+4,700
New +$60.1K ﹤0.01% 1243
2023
Q1 		– Sell
-3,438
Closed -$67.1K – 1788
2022
Q4 		$67.1K Sell
3,438
-962
-22% -$18.8K ﹤0.01% 1246
2022
Q3 		$83K Buy
4,400
+1,026
+30% +$23.6K 0.01% 1146
2022
Q2 		$69K Buy
+3,374
New +$80.1K 0.01% 1229

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Quantbot Technologies's ITOS Position: Q4 2023 in Review

Quantbot Technologies sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 4,700 shares — an estimated $51.5K sold.

Quantbot Technologies first reported a position in ITOS in Q2 2022 and held it in 4 quarters. The position peaked at $83K in Q3 2022. 137 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • Quantbot Technologies reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Quantbot Technologies sold 4,700 iTeos Therapeutics shares in Q4 2023, an estimated $51.5K.
  • Quantbot Technologies first reported a position in iTeos Therapeutics in Q2 2022 and held it in 4 quarters.
  • Quantbot Technologies's iTeos Therapeutics position peaked at $83K in Q3 2022.
  • 137 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Quantbot Technologies's 13F filing for Q4 2023, filed 14 Feb 2024.